- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NTLA
Recent news which mentions NTLA
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
From Benzinga
From Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
From Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
From Motley Fool
From Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
From Benzinga
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
February 28, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
February 07, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 01, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
From Benzinga
A Deep Dive Into the Video Game Industry
January 29, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
5 Charts to Remember if the Stock Market Crashes in 2022
January 19, 2022
From Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
From Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today
January 13, 2022
Tickers
NTLA
From Benzinga
"Motley Fool Money" 2022 Investing Preview
January 07, 2022
From Motley Fool
What 4 Analyst Ratings Have To Say About Intellia Therapeutics
January 07, 2022
Tickers
NTLA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
From Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.